Teva Pharmaceutical Industries Ltd is recalling certain combinations of blood pressure drug valsartan in the United States following the detection of a probable cancer-causing impurity, the latest global recall of the medicine.
The Israeli drug maker will recall all lots of amlodipine-valsartan and amlodipine-valsartan-hydrochlorothiazide combination tablets due to an impurity in an ingredient made by an India-based unit of Mylan, the U.S. Food and Drug Administration (FDA) said.
The European Union last week effectively banned here sales of valsartan made by the Mylan India unit after some batches were found to contain the same impurity, N-nitrosodiethylamine.
Check with your Pharmacist before taking any action.
No comments:
Post a Comment